Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2012
08/22/2012CN102188494B Medicament for treating high fever of pigs with pure Chinese medicine
08/22/2012CN102119821B Health-protecting material, application thereof in preparing health-protecting pillow and cushion, and health-protecting pillow and cushion
08/22/2012CN102114165B Plaster for treating pain of cervical and lumbar vertebrae and preparation method thereof
08/22/2012CN102106965B Composition for treating acute injury of soft tissue and application thereof
08/22/2012CN102085367B Application of optimized TACI (Transmembrane Activator and CAML Interactor)-Fc fusion protein in preparation of medicaments for treating rheumatoid arthritis
08/22/2012CN102078567B Pill capable of promoting blood circulation, dispersing pathogenic wind and activating collaterals
08/22/2012CN102068434B Application of 4-(cyclohexyl)-aminoquinazoline compounds
08/22/2012CN102038869B Quality control method of traditional Chinese medical preparation
08/22/2012CN101978997B Externally-applied cream for treating wind-heat cold by adopting transdermal absorption technology
08/22/2012CN101978963B Annonaceous acetogenin extract, preparation method thereof and use thereof in cancer resistance and relief of cancerous pain
08/22/2012CN101967113B 3-alloc amido-3-(3- nitryl-4-fluorophenyl) propionic acid and preparation method thereof
08/22/2012CN101962349B 3-Boc amidocyanogen-3-(3-nitryl-4-fluorophenyl) monoprop and preparation method thereof
08/22/2012CN101926755B In-situ gel preparation of potassium dehydroandrographolide succinate and preparation method thereof
08/22/2012CN101721480B Traditional Chinese medicine composition for treating diseases of bone, joint and skin and preparation method thereof
08/22/2012CN101612147B Application of alpha-mangostin in preparing inflammation-resisting pain-relieving medicine
08/22/2012CN101485751B Cotinus coggygria compound preparation and use
08/22/2012CN101346346B Amine compound and use thereof for medical purposes
08/22/2012CN101291947B Crystalline forms of macrolide compounds endowed with antiinflammatory activity
08/22/2012CN101057951B Plaster for auxiliary curing rheumatoid disease and its preparing method
08/21/2012US8247408 Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer
08/21/2012US8246982 Pressure-sensitive adhesives based on ethylene-vinyl acetate copolymers and adhesive resins, for medical application purposes
08/21/2012US8246958 Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
08/21/2012CA2674379C Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
08/21/2012CA2566215C Cyclohexyl-1,4-diamines substituted by acid derivatives
08/21/2012CA2473886C Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
08/21/2012CA2449284C Alpha-fetoprotein peptides and uses thereof
08/21/2012CA2398264C Use of desloratadine for treating allergic and inflammatory conditions
08/21/2012CA2233924C Novel stable liquid paracetamol compositions, and method for preparing same
08/16/2012WO2012109464A2 Modified peptide that reduces pain in peripheral neuropathy
08/16/2012WO2012109100A1 Substituted benzimdazole derivatives useful as trpm8 receptor modulators
08/16/2012WO2012108828A1 Citrate free pharmaceutical compositions comprising anakinra
08/16/2012WO2012107500A1 [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
08/16/2012WO2012106995A1 Rorgammat inhibitors
08/16/2012WO2012071414A3 Quinoxaline compounds and uses thereof
08/16/2012WO2012051126A3 Anti-inflammatory macrolides
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120209012 Compounds, compositions and methods
08/16/2012US20120208900 Methods of predicting the need for surgery in crohn's disease
08/16/2012US20120208899 Tool for Assessment of Symptoms of Irritable Bowel Syndrome
08/16/2012US20120208895 Composite material with properties of self-healing and release of active ingredients, for biomedical applications
08/16/2012US20120208893 Nutritional compositions for modulating inflammation including exogenous vitamin k2
08/16/2012US20120208891 Methods for concomitant administration of colchicine and a second active agent
08/16/2012US20120208889 Class- and isoform-specific hdac inhibitors and uses thereof
08/16/2012US20120208887 Stable, liquid, ready-to-use ketoprofen formulations
08/16/2012US20120208881 Methods for concomitant administration of colchicine and a second active agent
08/16/2012US20120208876 Amino acid derivatives for the treatment of neuropathic pain
08/16/2012US20120208867 Hmgb1 binding nucleic acid molecule and applications thereof
08/16/2012US20120208859 Novel mek inhibitors useful in the treatment of diseases
08/16/2012US20120208858 Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
08/16/2012US20120208849 Methods for controlling pain in canines using a transdermal solution of fentanyl
08/16/2012US20120208842 Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
08/16/2012US20120208840 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors
08/16/2012US20120208839 New compounds
08/16/2012US20120208829 2-phenoxy pyrimidinone analogues
08/16/2012US20120208821 Alpha adrenergic receptor modulators
08/16/2012US20120208820 Diazabicyclic central nervous system active agents
08/16/2012US20120208818 Compounds useful as antagonists of ccr2
08/16/2012US20120208817 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/16/2012US20120208814 Thetrahydroquinolines Derivatives As Bromodomain Inhibitors
08/16/2012US20120208807 Tofa analogs useful in treating dermatological disorders or conditions
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208800 Bromodomain Inhibitors For Treating Autoimmune And Inflammatory Diseases
08/16/2012US20120208799 Compounds
08/16/2012US20120208798 Tetrahydroquinoline Derivatives And Their Pharmaceutical Use
08/16/2012US20120208793 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
08/16/2012US20120208792 Protein kinase modulators
08/16/2012US20120208790 Ion channel modulators and methods of use
08/16/2012US20120208785 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
08/16/2012US20120208768 Specific binding sites in collagen for integrins and use thereof
08/16/2012US20120208751 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
08/16/2012US20120207854 Metal polysulfide-complex with biological and chemical activity
08/16/2012US20120207845 Pharmaceutical composition of nanoparticles
08/16/2012US20120207831 Coated solid dosage forms
08/16/2012US20120207825 Pharmaceutical compositions for reducing alcohol-induced dose dumping
08/16/2012US20120207823 Pharmaceutical pellets comprising modified starch and therapeutic applications therefor
08/16/2012US20120207818 Composition for suppressing expression of target gene
08/16/2012US20120207814 Aqueous patches containing diclofenac sodium
08/16/2012US20120207812 Skincare compositions comprising salicyclic acid
08/16/2012US20120207790 Immunosuppressing agent comprising mesenchymal stem cell derived from adipose tissue, and use thereof
08/16/2012US20120207773 Materials and methods for the development of an antigen-specific immune non-responsiveness state
08/16/2012US20120207761 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
08/16/2012US20120207752 Methods for modulating il-33 activity
08/16/2012US20120207743 Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases
08/16/2012US20120207735 Non-cytotoxic protein conjugates
08/16/2012US20120207734 Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases
08/16/2012US20120207726 Autism-associated biomarkers and uses thereof
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207704 Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases
08/16/2012US20120207700 Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing at a site of treatment
08/16/2012US20120207688 Rosacea Topical Skin Treatment Method and Formulation
08/16/2012US20120207685 Non-ozone depleting medicinal formulations with low greenhouse effect
08/16/2012US20120207670 Method for Treating Psoriasis by Administering An Anti-IL-12 Antibody
08/16/2012US20120204871 Stable, non-corrosive formulations for pressurized metered dose inhalers
08/16/2012CA2828059A1 Rorgammat inhibitors
08/16/2012CA2824578A1 Citrate free pharmaceutical compositions comprising anakinra
08/15/2012EP2487159A1 RorgammaT inhibitors
08/15/2012EP2486924A2 Drugs and uses
08/15/2012EP2486042A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists
08/15/2012EP2486009A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
08/15/2012EP2485760A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 1272